Add like
Add dislike
Add to saved papers

Serous retinal detachment as a presenting feature of chronic myelogenous leukemia.

PURPOSE: The purpose of this study was to report a case of diffuse unilateral retinal detachment as an initial symptom of chronic myelogenous leukemia in a 35-year-old woman.

METHODS: This is a case report of a 35-year-old white woman who presented with painless acute visual loss in her left eye.

RESULTS: A 35-year-old white woman presented with acute visual loss in her left eye. She had no systemic or ophthalmological medical history. Slit-lamp examination was normal in both eyes. Fundus examination of the left eye showed not only multiple retinal hemorrhages but also a diffuse serous retinal detachment affecting the nasal aspect of the retina and the posterior pole. The leukocyte count was 124,000/mm (99% blasts), and the Philadelphia chromosome was positive, an abnormality that is associated with chronic myelogenous leukemia.

CONCLUSION: Serous retinal detachment is an uncommon feature among leukemias. Chronic myelogenous leukemia may remain asymptomatic until a blastic phase occurs. Prompt recognition of the disease leads to early systemic chemotherapy and may help to restore visual function.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app